InvestorsHub Logo
icon url

Monroe1

02/27/24 11:23 AM

#230168 RE: kgromax #230167

LMAO, who is calling the kettle black now!!!

Try proving up your statements. Come on Chubby let's twist it again.
$CYDY$ 2024

Leronlimab, in a class of it's own. A monoclonal antibody that works and has almost no side effects except maybe a runny nose. Although the thought of leronlimab getting back into trials has some short traders squirming. Go Dr.Jay.
Bullish
Bullish